Traditional venture capital models struggle to support the long-term nature of biotech startups, particularly in fields like gene therapy that require extended investment periods. Unlike software ventures, breakthroughs in drug discovery often exceed the typical two- to three-year investment cycle, posing a challenge for sustaining funding. This mismatch hinders the growth and success of Australian […]

Five Australian biotech startups have collectively raised $64.8 million in funding this week. This significant financial boost underscores the growth and potential of the biotech industry in Australia, showcasing the innovation and investor confidence in this sector. Biotechnology, a field that merges biology and technology to develop products and technologies that improve lives, is a […]